Pharmafile Logo

Women Leaders Rewriting the Protocols of Rare Disease Care

The true measure of a medical leader is the courage to act when existing systems fail the patient. This is the professional and personal ethos of clinical immunologist Dr. Hilary Longhurst and clinical scientist Mrinal Shah. These women are not only advancing the science of gene editing for rare diseases like Hereditary Angioedema (HAE), but are defining a new standard for female leadership in a high-stakes field.

- PMLiVE

Listen to the full episode here. 

Overcoming Challenges in Female Leadership
Dr. Longhurst spoke about navigating medicine as a woman, recalling moments when her voice was challenged and she felt underestimated. She learned a profound lesson from experience: her greatest professional fears were often “sins of omission”—the failure to act out of caution.

  • This self-correction fueled her conviction: “The worst thing that could happen is to become one of those people who doesn’t do what’s right.”
  • This philosophy led her to take an unconventional path for an HAE patient whose life was transformed from decades of unemployment to a thriving career.

Listen to the full episode here. 

The Power of Patient Advocacy and Transformation
This patient’s story demonstrates that an individual’s brave decision can drive systemic change in rare disease care. For Dr. Longhurst, success means stepping outside rigid guidelines and being brave enough to “represent your patient.”

Responsible Innovation and Protecting Curiosity
For Mrinal Shah, Director of Clinical Development at Intellia Therapeutics, responsible innovation requires protecting creativity and curiosity, especially in a large organization. She emphasizes the importance of the patient voice and transparency.

  • Mrinal champions a critical skill for the next generation of women scientists: being unafraid to ask fundamental questions.
  • She noted that by simply asking, “somebody inevitably will be like, oh, I’m so glad you asked, because I didn’t know what the answer was either.”
  • This openness is foundational to her team’s work in advancing novel science, specifically the one-time, curative potential of gene editing for HAE.

Listen to the full episode here. 

A Vision for the Future
The impact of their work confirms that breakthroughs are not isolated events. They are a powerful fusion of diverse expertise: courageous clinicians, scientific rigor, and unwavering patient advocacy.

Their collective message to aspiring women leaders in science and medicine is a powerful call to action: “Take your opportunities, and dream, because you can be part of making that thing happen.” Through this blend of passion and pragmatic innovation, these women are fundamentally redefining the future of medicine.

Listen to the full episode here. 

Follow us for updates on upcoming podcasts and more insightful conversations.

For more information, please contact Jelena Spyropoulos.

About Medscape Education

Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses for physicians, nurses, and other healthcare professional

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Redefining Pediatric Epilepsy Care: Why We Must Move Beyond Symptom Suppression

For families navigating pediatric epilepsy, the condition dictates every moment of their lives. The constant, crippling “anticipatory anxiety” of when the next seizure might hit transforms daily activities like grocery…

What 90 Minutes of Live AI Case Practice Revealed About Physician Readiness

At EHA 2026 in Stockholm, 425 hematologists and oncologists attended an independent, 90-minute Medscape symposium on the practical and ethical use of AI. The format was case-based. The faculty presented…

Rethinking Prenatal Migraine Management: The Clinical Case for Neuromodulation

Disclaimer: Management of migraine in pregnancy typically combines lifestyle strategies, nonpharmacologic approaches, selected pharmacologic options when benefits outweigh risks, and, increasingly, noninvasive neuromodulation technologies.

Advancing the Frontier of Cancer Care: Medscape’s Mission at ESMO 2026

For more than 30 years, Medscape Education’s dedication has been centered on a single goal: building independent, accredited oncology education that improves patient outcomes. This year, at the European Society…

Using AI Responsibly in CME Outcomes Reporting

ICYMI at #AIS2026: using AI in outcomes reporting is a lot like onboarding a research assistant. There’s real efficiency in having the help, and a significant amount of background teaching,…

The Pulse of AI Innovation: From More Data to Better Care

At the European Society of Cardiology (ESC) Congress, two of cardiology’s most influential voices sat down to talk about artificial intelligence at Medscape’s ‘The Pulse of AI Innovation’ event: Professor…

Next-Level Clinical Practice, Real-World Impact: Evolving Patient Simulation with the Clinical Readiness Studio

Healthcare is changing rapidly, bringing unprecedented data and complex treatment pathways to the point of care. Clinical mastery requires active experience, the confidence to make decisions when real patient outcomes…

Medscape Sponsors The John Ritter Foundation’s “Evening From the Heart”

When independent, evidence-based education directly connects with clinicians at the point of care, clinical practice changes. Driven by this vital mission, Medscape Education was proud to sponsor The John Ritter…

From Booth to Bavaria: A Recap of Impact at ESC 2026

We have officially wrapped up another year at ESC. For Medscape Education, 4 days on the ground confirmed what 3 decades of cardiovascular education have already shown: when independent, evidence-based…

Why Modern Dermatology Demands Curiosity Over Precision

In the high-stakes world of healthcare research and product development, success has long been measured by rigid definitions of precision and predictable trajectories. However, as Dr. Hawa Dumbuya, Director of…